The insulin sensitizers, metformin, and thiazolidinediones (TZDs) are promising cancer therapies, because they not only lower glucose, insulin and fatty acid levels, but also may have unique anticarcinogenic properties that will be discussed below. This evidence concerns the gene INS and cancer.